Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
EXPERIENCE IN DOUBLE-CARBAPENEM THERAPY FOR CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE INFECTION
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: LIAO, Ling-Hui (Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan, Pharmacy Department, China Taiwan)
- Co-author(s): Rung-Wei Zhang: Pharmacy Department, Tungs’ Taichung MetroHarbor Hospital., Taichung City, China Taiwan;, Taichung City New Pharmacist Association., Taichung City, China Taiwan
Ling-Hui Liao: Pharmacy Department, Tungs’ Taichung MetroHarbor Hospital., Taichung City, China Taiwan;, Taichung City New Pharmacist Association., Taichung City, China Taiwan
BackgroundRecent data had evaluated ertapenem-containing double-carbapenem therapy (ECDCT) as an alternative regimen to treat carbapenem-resistant Klebsiella pneumonia(CRKP). Synergic bactericidal activity had been shown when ertapenem were given in combination with meropenem or doripenem, but no report mentioned imipenem.
MethodsIt was a.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019